Abstract
Summary
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global market for Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
China Vaccine market size was US$ million in 2023, while the US and Europe Vaccine were US$ million and US$ million, severally. The proportion of the US was % in 2023, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2030, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vaccine landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period.
The global key companies of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc. In 2023, the global five largest players have a share approximately % in terms of revenue.
In 2023, Varicella Vaccine segment accounted for a share of % in the global Vaccine market. And this product segment is poised to reach US$ million by 2030 from US$ million in 2023.
In Vaccine market, the For Adult segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2030, at a CAGR of % during 2024 and 2030.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Vaccine.
The Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Segment by Type
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Segment by Application
For Adult
For Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Vaccine in global and regional level.
Chapter 3: Detailed analysis of Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
The global market for Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
China Vaccine market size was US$ million in 2023, while the US and Europe Vaccine were US$ million and US$ million, severally. The proportion of the US was % in 2023, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2030, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vaccine landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period.
The global key companies of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc. In 2023, the global five largest players have a share approximately % in terms of revenue.
In 2023, Varicella Vaccine segment accounted for a share of % in the global Vaccine market. And this product segment is poised to reach US$ million by 2030 from US$ million in 2023.
In Vaccine market, the For Adult segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2030, at a CAGR of % during 2024 and 2030.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Vaccine.
The Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Segment by Type
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Segment by Application
For Adult
For Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Vaccine in global and regional level.
Chapter 3: Detailed analysis of Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Study Coverage
1.1 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 For Adult
1.3.3 For Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccine Market Size Estimates and Forecasts
2.2 Vaccine Market Size by Region: 2023 Versus 2030
2.2.1 Global Vaccine Revenue by Region: 2019-2024
2.2.2 Global Vaccine Revenue Forecast by Region (2025-2030)
2.2.3 Global Vaccine Revenue Market Share by Region (2019-2030)
3 Global Vaccine by Company
3.1 Global Vaccine Revenue by Company (2019-2024)
3.2 Global Vaccine Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Vaccine Companies around the World: Ranking by Revenue
3.3.2 Global Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Vaccine Companies Headquarters & Product Type
3.4.1 Vaccine Companies Headquarters
3.4.2 Global Vaccine Companies Product & Service
3.4.3 Date of International Companies Enter into Vaccine Market
3.5 Global Vaccine Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AstraZeneca
4.1.1 AstraZeneca Company Information
4.1.2 AstraZeneca Description, Business Overview
4.1.3 AstraZeneca Vaccine Products Offered
4.1.4 AstraZeneca Vaccine Revenue and Gross Margin (2019-2024)
4.1.5 AstraZeneca Vaccine Revenue by Product in 2023
4.1.6 AstraZeneca Vaccine Revenue by Application in 2023
4.1.7 AstraZeneca Vaccine Revenue by Geographic Area in 2023
4.1.8 AstraZeneca Recent Developments
4.2 BioNTech
4.2.1 BioNTech Company Information
4.2.2 BioNTech Description, Business Overview
4.2.3 BioNTech Vaccine Products Offered
4.2.4 BioNTech Vaccine Revenue and Gross Margin (2019-2024)
4.2.5 BioNTech Vaccine Revenue by Product in 2023
4.2.6 BioNTech Vaccine Revenue by Application in 2023
4.2.7 BioNTech Vaccine Revenue by Geographic Area in 2023
4.2.8 BioNTech Recent Developments
4.3 Boehringer-Ingelheim
4.3.1 Boehringer-Ingelheim Company Information
4.3.2 Boehringer-Ingelheim Description, Business Overview
4.3.3 Boehringer-Ingelheim Vaccine Products Offered
4.3.4 Boehringer-Ingelheim Vaccine Revenue and Gross Margin (2019-2024)
4.3.5 Boehringer-Ingelheim Vaccine Revenue by Product in 2023
4.3.6 Boehringer-Ingelheim Vaccine Revenue by Application in 2023
4.3.7 Boehringer-Ingelheim Vaccine Revenue by Geographic Area in 2023
4.3.8 Boehringer-Ingelheim Recent Developments
4.4 CCBIO
4.4.1 CCBIO Company Information
4.4.2 CCBIO Description, Business Overview
4.4.3 CCBIO Vaccine Products Offered
4.4.4 CCBIO Vaccine Revenue and Gross Margin (2019-2024)
4.4.5 CCBIO Vaccine Revenue by Product in 2023
4.4.6 CCBIO Vaccine Revenue by Application in 2023
4.4.7 CCBIO Vaccine Revenue by Geographic Area in 2023
4.4.8 CCBIO Recent Developments
4.5 CSL
4.5.1 CSL Company Information
4.5.2 CSL Description, Business Overview
4.5.3 CSL Vaccine Products Offered
4.5.4 CSL Vaccine Revenue and Gross Margin (2019-2024)
4.5.5 CSL Vaccine Revenue by Product in 2023
4.5.6 CSL Vaccine Revenue by Application in 2023
4.5.7 CSL Vaccine Revenue by Geographic Area in 2023
4.5.8 CSL Recent Developments
4.6 CureVac
4.6.1 CureVac Company Information
4.6.2 CureVac Description, Business Overview
4.6.3 CureVac Vaccine Products Offered
4.6.4 CureVac Vaccine Revenue and Gross Margin (2019-2024)
4.6.5 CureVac Vaccine Revenue by Product in 2023
4.6.6 CureVac Vaccine Revenue by Application in 2023
4.6.7 CureVac Vaccine Revenue by Geographic Area in 2023
4.6.8 CureVac Recent Development
4.7 Elanco
4.7.1 Elanco Company Information
4.7.2 Elanco Description, Business Overview
4.7.3 Elanco Vaccine Products Offered
4.7.4 Elanco Vaccine Revenue and Gross Margin (2019-2024)
4.7.5 Elanco Vaccine Revenue by Product in 2023
4.7.6 Elanco Vaccine Revenue by Application in 2023
4.7.7 Elanco Vaccine Revenue by Geographic Area in 2023
4.7.8 Elanco Recent Development
4.8 GSK
4.8.1 GSK Company Information
4.8.2 GSK Description, Business Overview
4.8.3 GSK Vaccine Products Offered
4.8.4 GSK Vaccine Revenue and Gross Margin (2019-2024)
4.8.5 GSK Vaccine Revenue by Product in 2023
4.8.6 GSK Vaccine Revenue by Application in 2023
4.8.7 GSK Vaccine Revenue by Geographic Area in 2023
4.8.8 GSK Recent Development
4.9 Hulan Bio
4.9.1 Hulan Bio Company Information
4.9.2 Hulan Bio Description, Business Overview
4.9.3 Hulan Bio Vaccine Products Offered
4.9.4 Hulan Bio Vaccine Revenue and Gross Margin (2019-2024)
4.9.5 Hulan Bio Vaccine Revenue by Product in 2023
4.9.6 Hulan Bio Vaccine Revenue by Application in 2023
4.9.7 Hulan Bio Vaccine Revenue by Geographic Area in 2023
4.9.8 Hulan Bio Recent Development
4.10 Indian Immunologicals
4.10.1 Indian Immunologicals Company Information
4.10.2 Indian Immunologicals Description, Business Overview
4.10.3 Indian Immunologicals Vaccine Products Offered
4.10.4 Indian Immunologicals Vaccine Revenue and Gross Margin (2019-2024)
4.10.5 Indian Immunologicals Vaccine Revenue by Product in 2023
4.10.6 Indian Immunologicals Vaccine Revenue by Application in 2023
4.10.7 Indian Immunologicals Vaccine Revenue by Geographic Area in 2023
4.10.8 Indian Immunologicals Recent Development
4.11 Merck
4.11.1 Merck Company Information
4.11.2 Merck Description, Business Overview
4.11.3 Merck Vaccine Products Offered
4.11.4 Merck Vaccine Revenue and Gross Margin (2019-2024)
4.11.5 Merck Vaccine Revenue by Product in 2023
4.11.6 Merck Vaccine Revenue by Application in 2023
4.11.7 Merck Vaccine Revenue by Geographic Area in 2023
4.11.8 Merck Recent Development
4.12 Minhai Biotechnology
4.12.1 Minhai Biotechnology Company Information
4.12.2 Minhai Biotechnology Description, Business Overview
4.12.3 Minhai Biotechnology Vaccine Products Offered
4.12.4 Minhai Biotechnology Vaccine Revenue and Gross Margin (2019-2024)
4.12.5 Minhai Biotechnology Vaccine Revenue by Product in 2023
4.12.6 Minhai Biotechnology Vaccine Revenue by Application in 2023
4.12.7 Minhai Biotechnology Vaccine Revenue by Geographic Area in 2023
4.12.8 Minhai Biotechnology Recent Development
4.13 Mitsubishi Tanabe Pharma
4.13.1 Mitsubishi Tanabe Pharma Company Information
4.13.2 Mitsubishi Tanabe Pharma Description, Business Overview
4.13.3 Mitsubishi Tanabe Pharma Vaccine Products Offered
4.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue and Gross Margin (2019-2024)
4.13.5 Mitsubishi Tanabe Pharma Vaccine Revenue by Product in 2023
4.13.6 Mitsubishi Tanabe Pharma Vaccine Revenue by Application in 2023
4.13.7 Mitsubishi Tanabe Pharma Vaccine Revenue by Geographic Area in 2023
4.13.8 Mitsubishi Tanabe Pharma Recent Development
4.14 Moderna Therapeutics
4.14.1 Moderna Therapeutics Company Information
4.14.2 Moderna Therapeutics Description, Business Overview
4.14.3 Moderna Therapeutics Vaccine Products Offered
4.14.4 Moderna Therapeutics Vaccine Revenue and Gross Margin (2019-2024)
4.14.5 Moderna Therapeutics Vaccine Revenue by Product in 2023
4.14.6 Moderna Therapeutics Vaccine Revenue by Application in 2023
4.14.7 Moderna Therapeutics Vaccine Revenue by Geographic Area in 2023
4.14.8 Moderna Therapeutics Recent Development
4.15 Mylan
4.15.1 Mylan Company Information
4.15.2 Mylan Description, Business Overview
4.15.3 Mylan Vaccine Products Offered
4.15.4 Mylan Vaccine Revenue and Gross Margin (2019-2024)
4.15.5 Mylan Vaccine Revenue by Product in 2023
4.15.6 Mylan Vaccine Revenue by Application in 2023
4.15.7 Mylan Vaccine Revenue by Geographic Area in 2023
4.15.8 Mylan Recent Development
4.16 Plumbline Life Sciences
4.16.1 Plumbline Life Sciences Company Information
4.16.2 Plumbline Life Sciences Description, Business Overview
4.16.3 Plumbline Life Sciences Vaccine Products Offered
4.16.4 Plumbline Life Sciences Vaccine Revenue and Gross Margin (2019-2024)
4.16.5 Plumbline Life Sciences Vaccine Revenue by Product in 2023
4.16.6 Plumbline Life Sciences Vaccine Revenue by Application in 2023
4.16.7 Plumbline Life Sciences Vaccine Revenue by Geographic Area in 2023
4.16.8 Plumbline Life Sciences Recent Development
4.17 Sanofi
4.17.1 Sanofi Company Information
4.17.2 Sanofi Description, Business Overview
4.17.3 Sanofi Vaccine Products Offered
4.17.4 Sanofi Vaccine Revenue and Gross Margin (2019-2024)
4.17.5 Sanofi Vaccine Revenue by Product in 2023
4.17.6 Sanofi Vaccine Revenue by Application in 2023
4.17.7 Sanofi Vaccine Revenue by Geographic Area in 2023
4.17.8 Sanofi Recent Development
4.18 Translate Bio
4.18.1 Translate Bio Company Information
4.18.2 Translate Bio Description, Business Overview
4.18.3 Translate Bio Vaccine Products Offered
4.18.4 Translate Bio Vaccine Revenue and Gross Margin (2019-2024)
4.18.5 Translate Bio Vaccine Revenue by Product in 2023
4.18.6 Translate Bio Vaccine Revenue by Application in 2023
4.18.7 Translate Bio Vaccine Revenue by Geographic Area in 2023
4.18.8 Translate Bio Recent Development
4.19 Walvax Biotechnology
4.19.1 Walvax Biotechnology Company Information
4.19.2 Walvax Biotechnology Description, Business Overview
4.19.3 Walvax Biotechnology Vaccine Products Offered
4.19.4 Walvax Biotechnology Vaccine Revenue and Gross Margin (2019-2024)
4.19.5 Walvax Biotechnology Vaccine Revenue by Product in 2023
4.19.6 Walvax Biotechnology Vaccine Revenue by Application in 2023
4.19.7 Walvax Biotechnology Vaccine Revenue by Geographic Area in 2023
4.19.8 Walvax Biotechnology Recent Development
4.20 Wuhan Institute of Biological Products
4.20.1 Wuhan Institute of Biological Products Company Information
4.20.2 Wuhan Institute of Biological Products Description, Business Overview
4.20.3 Wuhan Institute of Biological Products Vaccine Products Offered
4.20.4 Wuhan Institute of Biological Products Vaccine Revenue and Gross Margin (2019-2024)
4.20.5 Wuhan Institute of Biological Products Vaccine Revenue by Product in 2023
4.20.6 Wuhan Institute of Biological Products Vaccine Revenue by Application in 2023
4.20.7 Wuhan Institute of Biological Products Vaccine Revenue by Geographic Area in 2023
4.20.8 Wuhan Institute of Biological Products Recent Development
4.21 Zoties
4.21.1 Zoties Company Information
4.21.2 Zoties Description, Business Overview
4.21.3 Zoties Vaccine Products Offered
4.21.4 Zoties Vaccine Revenue and Gross Margin (2019-2024)
4.21.5 Zoties Vaccine Revenue by Product in 2023
4.21.6 Zoties Vaccine Revenue by Application in 2023
4.21.7 Zoties Vaccine Revenue by Geographic Area in 2023
4.21.8 Zoties Recent Development
5 Breakdown Data by Type
5.1 Global Vaccine Revenue by Type (2019-2024)
5.2 Global Vaccine Revenue Forecast by Type (2025-2030)
5.3 Vaccine Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Vaccine Revenue by Application (2019-2024)
6.2 Global Vaccine Revenue Forecast by Application (2025-2030)
6.3 Vaccine Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Vaccine Market Size YoY Growth 2019-2030
7.2 North America Vaccine Market Facts & Figures by Country (2019-2030)
7.3 North America Vaccine Revenue by Type (2019-2024)
7.4 North America Vaccine Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Vaccine Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Vaccine Revenue by Type (2019-2024)
8.4 Asia-Pacific Vaccine Revenue by Application (2019-2024)
9 Europe
9.1 Europe Vaccine Market Size YoY Growth 2019-2030
9.2 Europe Vaccine Market Facts & Figures by Country (2019-2030)
9.3 Europe Vaccine Revenue by Type (2019-2024)
9.4 Europe Vaccine Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Vaccine Market Size YoY Growth 2019-2030
10.2 Latin America Vaccine Market Facts & Figures by Country (2019-2030)
10.3 Latin America Vaccine Revenue by Type (2019-2024)
10.4 Latin America Vaccine Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Vaccine Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Vaccine Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Vaccine Revenue by Type (2019-2024)
11.4 Middle East and Africa Vaccine Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Vaccine Supply Chain Analysis
12.2 Vaccine Key Raw Materials and Upstream Suppliers
12.3 Vaccine Clients Analysis
12.4 Vaccine Sales Channel and Sales Model Analysis
12.4.1 Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Vaccine Distributors
13 Market Dynamics
13.1 Vaccine Industry Trends
13.2 Vaccine Market Drivers
13.3 Vaccine Market Challenges
13.4 Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer